As you know, the healthcare industry went through a major change with the implementation of ICD-10 codes on October 1, 2015. We want to ensure you that we are ICD-10 ready and are currently prepared to receive and process ICD-10 codes.
The International Conference on Nutrition in Medicine will be held in Washington, D.C. , July 31st and August 1st, 2015. CHL is pleased to be an educational sponsor for the International Conference on Nutrition in Medicine, where Dr. Marc Penn will be speaking on “Laboratory tests: Which Ones Do I Need and Not Need?” Come join us and make sure more »
Dear Colleagues, Upon completion of our 5th Annual symposium, “Where Inflammation Meets Lipids”, I believe it is an opportune time for a comment regarding our thoughts on the ACC/AHA National Cholesterol Guidelines. At this symposium we had a lively and detailed discussion/debate on the new guidelines and we are grateful to all that participated. We at Cleveland HeartLab support the more »
NEW YORK (CNNMoney) “Down the street from Jake Orville’s office in downtown Cleveland, you can hear the cutting of steel gears from a nearly 100-year-old manufacturer of machinery parts. Just beyond that lies Millionaire’s Row, a stretch of historic homes built by industrial tycoons like John Rockefeller and Western Union founder Jeptha Wade, who dominated the city in the late more »
CLEVELAND, March 27, 2014 – Jake Orville, CEO of Cleveland HeartLab, accepted today the Crystal Award for Excellence from Ohio’s Edison Technology Centers. The presentation was made by its Edison Centers Director Council during a luncheon held at the Ohio statehouse and attended by state legislators and executives from other innovative companies. The six Edison Technology Centers located in Ohio more »
Yahoo Health discusses Study: HDL, the “Good” Cholesterol Can Be Bad for Your Heart. Published January 27, 2014. HDL — the so-called “good” cholesterol—sometimes goes rogue and clogs arteries instead of keeping them healthy, according to a groundbreaking new study published in Nature Medicine. …“These are great discoveries,” said Jake Orville, CEO of Cleveland HeartLab (CHL), which has licensed this test more »
…reported recently, the multi-marker approach identified 37 to 43 percent more at-risk patients than would have been found using levels of LDL (bad) cholesterol alone, scientists from Cleveland HeartLab and MDVIP found. This combination testing approach helped stratify which patients were at highest risk for a heart attack, according to lead study author Marc Penn, MD, PhD, chief medical officer of Cleveland HeartLab. more »
Marc Penn, MD, PhD, FACC discusses the Trials and Tribulations of Assessing CVD Risk in 2013 at the 2013 Cleveland HeartLab Symposium in Dallas, Texas. Listen as Dr. Marc Penn reviews strategies for defining cardiovascular risk based on novel biomarker tests. To open, Dr. Penn reviews recent literature that supports the lowering of hsCRP to reduce cardiovascular risk and initial more »
Dr. Marc Penn discusses the importance and impact that inflammation testing can have in your practice, providing a more complete picture of an individual’s risk for heart disease.
Cleveland HeartLab’s Chief Medical Officer, Marc Penn, MD, PhD discusses results of TEDMED attendees who got inflammation testing or “IT” during this year’s conference, held at the Kennedy Center in Washington, DC.
Watch Cleveland HeartLab CEO Jake Orville being interviewed by WREG Memphis Channel 3 about the importance of inflammation testing on their morning Live at Nine program.
Watch the Know Your Risk Video™ from Cleveland HeartLab to learn about the link between heart disease and inflammation. Hear how practitioners learn which patients are at high risk and from patients who have been tested. Patients can take action to reduce their risk of heart attacks and strokes. Yet heart disease kills one American every 34 seconds. It’s still the leading more »
CLEVELAND HEARTLAB ON TOUR IN NASHVILLE TO BRING EXCLUSIVE – ‘IT’ – INFLAMMATION TESTING TO ATTENDEES AT THE 2013 COUNTRY RADIO SEMINAR CHL to Provide Inflammation Testing at CRS as Part of American Heart Month CLEVELAND, Feb. 13, 2012 – Cleveland HeartLab (CHL), an advanced clinical laboratory focused on heart inflammation testing, is going on the road to provide the more »
CHL Inflammation Panel Featured in Worth Magazine Cleveland HeartLab’s Chief Medical Officer, Marc Penn, MD, PhD was featured in the August issue of Worth Magazine talking about the benefits of our Inflammation Panel as a predictor for heart disease and events.
For decades, much of Northeast Ohio’s growth migrated to the suburbs…new buildings, office parks, factories. But one local company has reversed that trend and is creating jobs and hope in downtown Cleveland. Like many others, Fred Geis’s family came to Northeast Ohio for a brighter future. He and his brother built a flourishing development company…then turned their attention from suburban more »
Cleveland’s WKYC featured Cleveland HeartLab in this recent news story about the growing biomedical business boom taking place in the region.
After making major inroads among community-based physicians, cardiac inflammation biomarker test company Cleveland HeartLab is looking to expand its business into the health and wellness market. The Cleveland-based clinical reference laboratory, which provides cardiovascular testing for thousands of U.S. physicians, is now aiming to partner with health and wellness companies and self-insured employers to diversify its customer base, CEO Jake more »
A story from MicrOHscope: Ohio’s Bioscience Blog and News Source – Cleveland HeartLab Wants Everyone to Know What “it” Is Cleveland HeartLab (CHL) chose the TEDMED Conference in D.C. last week to kick-off a campaign to educate patients and health care professionals about the importance of “it,” or inflammation testing, in determining heart attack and stroke risk. [Read More at more »
Watch this video to see how Cleveland HeartLab is helping to transform Cleveland’s MidTown neighborhood, located between downtown and University Circle.
Cardiac inflammation biomarker test company Cleveland HeartLab has been tapped as the Ohio Venture Association‘s ” venture of the year.” The last year has been an eventful one for the Cleveland-based company: It spurned a buyout offer from an unidentified Massachusetts suitor, closed an $18.4 million series B round of investment, moved into a new building that quadrupled its office more »
Cleveland HeartLab Inc., a company developing proprietary heart disease tests, has added three executives to its management team. Deborah H. Sun, Ph.D., has been appointed vice president of laboratory operations. Cleveland HeartLab said Dr. Sun has more than 20 years of experience in the field of clinical laboratory management. She most recently was scientific director of clinical pathology at South more »